Skip to content
ClinCalc Pro
Menu
Osmotic agent / ICP reduction

Hypertonic Saline 3%

Brand names: NaCl 3% Infusion

Used in: Head Injury

Hypertonic saline 3% is a concentrated sodium chloride solution used in neurocritical care to treat raised intracranial pressure and symptomatic hyponatraemia.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It raises serum osmolality, creating an osmotic gradient that draws water out of brain tissue across an intact blood-brain barrier, reducing cerebral oedema and intracranial pressure.

Prescribing in practice

  • Correct sodium too rapidly and you risk osmotic demyelination syndrome, so monitor serum sodium frequently and limit the rate of rise, particularly in chronic hyponatraemia.
  • Concentrated solutions are an irritant and are best given via central venous access where feasible, with close attention to the infusion site.
  • Use with caution in cardiac failure and volume overload, as the sodium load can precipitate pulmonary oedema.

Monitoring

Monitor serum sodium and osmolality regularly during therapy, alongside fluid balance and neurological status.

Counselling the patient

  • Explain to the team that frequent blood tests are needed to control the speed of sodium correction.
  • Report any new confusion, weakness or swallowing difficulty promptly.

Evidence & guidelines

Hypertonic saline is an established osmotherapy option for raised intracranial pressure and symptomatic hyponatraemia, with use guided by neurocritical care and electrolyte management consensus.

Reference: NICE NG234 TBI; BTF Guidelines 4th Edition; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.